Abstract
Colorectal cancer (CRC) has a 90% cure chance if the tumors are diagnosed in the early stages, therefore motivating the development and design of diagnostic methods for CRC detection. This work tested contrast enhancement of ultrasound images from mouse colon tumors using VEGFR2 (vascular endothelial growth factor receptor 2)-targeted ultrasound contrast agent (UCA) and 40 MHz endoluminal ultrasound biomicroscopy (eUBM).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
